CSIMarket
 


Erytech Pharma S a   (ERYP)
Other Ticker:  
 
 

ERYP's Free Cash Flow Growth by Quarter and Year

Erytech Pharma S A 's Free Cash Flow results by quarter and year




ERYP Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December -35.58 -63.58 -57.93 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -35.58 -63.58 -57.93 0.00



ERYP Free Cash Flow fourth quarter 2022 Y/Y Growth Comment
Erytech Pharma S a in the fourth quarter 2022 recorded free cash outflow of $ -35.58 millions.

According to the results reported in the fourth quarter 2022, Erytech Pharma S A achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Erytech Pharma S A ' s Free Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2022.




ERYP Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Erytech Pharma S A 's fourth quarter 2022 Free Cash Flow $ -35.58 millions ERYP's Income Statement
Erytech Pharma S A 's fourth quarter 2021 Free Cash Flow $ -63.58 millions Quarterly ERYP's Income Statement
New: More ERYP's historic Free Cash Flow Growth >>


ERYP Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Erytech Pharma S A 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ERYP's IV. Quarter Q/Q Free Cash Flow Comment


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ERYP's IV. Quarter Q/Q Free Cash Flow Comment


Erytech Pharma S A 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
0
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ -63.25
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
In the Dec 31 2022 period, Erytech Pharma S A 's cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Erytech Pharma S a achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
In the Dec 31 2022 period, Erytech Pharma S A 's cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Erytech Pharma S a achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ERYP's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ERYP's Competitors
Free Cash Flow Growth for Erytech Pharma S A 's Suppliers
Free Cash Flow Growth for ERYP's Customers

You may also want to know
ERYP's Annual Growth Rates ERYP's Profitability Ratios ERYP's Asset Turnover Ratio ERYP's Dividend Growth
ERYP's Roe ERYP's Valuation Ratios ERYP's Financial Strength Ratios ERYP's Dividend Payout Ratio
ERYP's Roa ERYP's Inventory Turnover Ratio ERYP's Growth Rates ERYP's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2022
Halozyme Therapeutics Inc -0.08%$ -0.076 millions
Bionexus Gene Lab Corp -1.77%$ -1.768 millions
Addus Homecare Corporation-3.61%$ -3.607 millions
Adapthealth Corp -3.97%$ -3.972 millions
3m Company-4.14%$ -4.140 millions
Novartis Ag-5.54%$ -5.540 millions
Amgen Inc -5.66%$ -5.662 millions
Laboratory Corporation Of America Holdings-6.29%$ -6.294 millions
Universal Health Services Inc -7.68%$ -7.675 millions
Henry Schein Inc-8.18%$ -8.184 millions
Airsculpt Technologies Inc -8.21%$ -8.208 millions
Alcon inc -9.52%$ -9.517 millions
Iradimed Corporation-9.72%$ -9.721 millions
Viemed Healthcare Inc -11.22%$ -11.219 millions
Fresenius Medical Care Ag-12.94%$ -12.939 millions
Merck and Co Inc -13.05%$ -13.052 millions
Steris Plc-15.86%$ -15.855 millions
Globus Medical Inc -16.10%$ -16.102 millions
Prestige Consumer Healthcare Inc -17.13%$ -17.127 millions
Idexx Laboratories Inc-17.40%$ -17.401 millions
Bristol myers Squibb Company-18.51%$ -18.511 millions
Envista Holdings Corporation-18.90%$ -18.897 millions
Iqvia Holdings Inc -19.08%$ -19.075 millions
Lemaitre Vascular Inc -19.36%$ -19.363 millions
Gilead Sciences Inc -19.91%$ -19.906 millions
Horizon Therapeutics Public Limited Company-20.83%$ -20.827 millions
Msa Safety Incorporated-22.39%$ -22.391 millions
Intuitive Surgical Inc -22.86%$ -22.864 millions
National Healthcare Corp-23.12%$ -23.121 millions
Exelixis Inc -23.60%$ -23.595 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com